Rani Therapeutics
RANI
RANI
34 hedge funds and large institutions have $6.96M invested in Rani Therapeutics in 2023 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 8 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
47% less capital invested
Capital invested by funds: $13.3M → $6.96M (-$6.29M)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $17K
Holders
34
Holding in Top 10
–
Calls
–
Puts
$17K
Top Buyers
| 1 | +$142K | |
| 2 | +$112K | |
| 3 | +$75.8K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$35.8K |
| 5 |
AWM
Activest Wealth Management
Aventure,
Florida
|
+$21.3K |
Top Sellers
| 1 | -$190K | |
| 2 | -$170K | |
| 3 | -$81K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$36.9K |
| 5 |
ASGS
Alpha Square Group S
New York
|
-$31.8K |